BMPR2 mutation has been reported as the most common mutation in both pediatrics and adults, comprising 6.5%–12.5% of all unexplained pediatric PAH and 36%–65% of pediatric PAH with pathogenic genetic variants (3, 5, 13, 15). Here, BMPR2 is linked to pulmonary arterial hypertension.